Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis (Q65471955)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis |
clinical trial |
Statements
A Two Year Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Fracture Efficacy and Safety of Intravenous Zoledronic Acid 5 mg Annually for the Treatment of Osteoporosis in Men (English)
0 references
December 2006
0 references
October 2010
0 references
1,199
0 references
50 year
0 references
85 year
0 references